|
|
Other links at Articles > Business of Medicine |
| 2. |
FDA Approvals: Rotarix and PegIntron/Rebetol
|
|
|
The FDA has approved an oral vaccine (Rotarix) and new recommendations for peginterferon alfa-2b (PegIntron) plus ribavirin (Rebetol) combination therapy. Medscape Medical News
|
| 3. |
New FDA Orphan Drugs: AVI-4658, SQ109, ATIR
|
|
|
The FDA has granted orphan drug designation to AVI-4658 for the treatment of Duchenne muscular dystrophy, SQ109 for the treatment of tuberculosis, and ATIR for the topical treatment of graft-versus-host disease. Medscape Medical News
|
| 4. |
UnitedHealth 1st-Qtr Profit Misses, Cuts Forecast
|
|
|
Health insurer UnitedHealth Group Inc posted a lower-than-expected first-quarter profit on Tuesday, hurt by weakness in its business serving employers, and slashed its full-year earnings forecast, sending its shares down as much as 11.5 percent. Reuters Health Information
|
|
|